236 related articles for article (PubMed ID: 10021294)
1. Effects of IL-12 on human ovarian tumors engrafted into SCID mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294
[TBL] [Abstract][Full Text] [Related]
2. Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
Silver DF; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 2000 Jun; 77(3):377-82. PubMed ID: 10831345
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect.
Silver DF; Piver MS
Gynecol Oncol; 1999 May; 73(2):280-4. PubMed ID: 10329047
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
6. Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.
Paine GD; Taylor CW; Lopez MH; Johnson CS; Capizzi RL
Semin Oncol; 1996 Aug; 23(4 Suppl 8):35-9. PubMed ID: 8783664
[TBL] [Abstract][Full Text] [Related]
7. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
8. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
10. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ
Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579
[TBL] [Abstract][Full Text] [Related]
11. [Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice].
Zhu H; Ye D; Chen H; Lu W; Xie X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):630-3. PubMed ID: 12133487
[TBL] [Abstract][Full Text] [Related]
12. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
Wang J; Zhang CQ; Liu J; Sui LH
Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy.
Sanches R; Kuiper M; Penault-Llorca F; Aunoble B; D'Incan C; Bignon YJ
Cancer Gene Ther; 2000 May; 7(5):707-20. PubMed ID: 10830718
[TBL] [Abstract][Full Text] [Related]
15. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
18. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of GnRH agonist in epithelial ovarian cancer.
Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE
Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728
[TBL] [Abstract][Full Text] [Related]
20. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects.
Ugai S; Shimozato O; Yu L; Wang YQ; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Oct; 10(10):771-8. PubMed ID: 14502230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
